The PM360 2026 Trailblazer Awards celebrated remarkable achievements in life sciences marketing, recognizing top companies, leaders, and innovative products at a gala in NYC.

The NCPDP Foundation has appointed Susan Carter as the new Executive Director and Chief Development Officer, focusing on healthcare advancement.

Parakeet Health has announced a successful $10 million Series A funding, showcasing dramatic growth and enhancing patient access through AI. This funding will further develop their unified platform.

A recent study showcases how AI-enhanced handheld ultrasound technology improves carotid plaque detection, potentially revolutionizing primary care diagnostics.

Jiahui Health emphasizes China's growing role in medical tourism at the WTO Public Forum, highlighting innovations and opportunities for international patients.

Carestream Healthcare has launched a cutting-edge digital radiography system, STARVIEW, designed for improved imaging workflows in hospitals. Learn more about its features!

MyPureSkin S.A has been recognized as one of the 20 Most Innovative Healthcare Companies to Watch in 2026 by Business Worldwide Magazine, showcasing its commitment to skin health through science.

Ayble Health raises $16M in Series A funding to expand its virtual clinic, addressing digestive and autoimmune health needs across the nation.

RadiantGraph introduces Care Guidance Agents designed to enhance chronic care management and improve patient outcomes, approved under CMS's ACCESS program.

Zocdoc is taking a bold step by launching its Care Access Network, revolutionizing how patients book healthcare appointments through various platforms.

Sogo Medical Group's 'Pharmacy Forum 2026' focuses on regional healthcare solutions, uniting pharmacists to tackle advancing medical challenges and innovations.

Vertex Health announces the strategic appointment of Dr. Jared Saul, a former AWS Chief Medical Officer, as Partner, highlighting its commitment to healthcare innovation.

In May 2027, Nashville will host Roundstone's Medical Captive Forum, a key event for health industry leaders to discuss transformative health plan strategies.

As healthcare shifts into homes, less than 4% meet basic accessibility standards. Discover the need for national standards with reliable scores.

Universal Health Services, Inc. is set to present at key healthcare conferences in September 2026, highlighting its industry innovations and growth.

Blue Shield of California has appointed Dr. Kedar S. Mate, an expert in healthcare innovation, to its board. His extensive experience will enhance the organization's mission to improve healthcare quality.

Kedar S. Mate, MD, renowned healthcare innovator, joins Blue Shield of California's Board of Directors, bringing extensive experience to enhance quality and access.

The Digital Therapeutics Market is anticipated to expand from $10.95 billion in 2026 to $35.37 billion by 2031, highlighting a CAGR of 26.4%.

The disposable syringes market is projected to grow significantly, reaching USD 24.94 billion by 2031 due to innovations and increased healthcare needs.

LEBM showcases its healthcare innovations at TAIWAN EXPO JAPAN 2026, seeking collaborations with Japanese firms for future projects and developments.

Fresenius announces a new venture fund exceeding €200 million aimed at fostering healthcare innovation and technologies over the next five years.

Aiming for innovation in the surgical landscape, Demetra collaborates with Masmec Biomed to enhance surgical navigation and AI technologies, shaping the future of healthcare.

A Toronto-based research team is leading a five-year clinical trial to study liquid biopsies, a blood-based technology that detects traces of tumour DNA to improve cancer survivorship. The SHERLOCK project, led by Dr. Lillian Siu at the Princess Margaret Cancer Centre, aims to identify residual cancer cells in patients who have undergone curative treatments. Liquid biopsies offer a less invasive alternative to traditional imaging, enabling early detection of potential relapses. Participants like Paul Lonergan, who had tongue cancer, benefited from the technology by receiving targeted immunotherapy after tests revealed lingering tumour fragments. While promising, challenges remain, including false positives/negatives and high costs. Researchers emphasize the need for repeated testing and long-term studies to validate the technology's role in routine care. Despite these hurdles, the project could revolutionize cancer monitoring by detecting disease recurrence before clinical symptoms appear, offering patients better treatment options and reducing the need for aggressive interventions.

Dr. Nicole L. Dyer has been named a Pinnacle Lifetime Member by The Inner Circle, acknowledging her impactful contributions to healthcare innovation and compassionate patient care.

Flagship Pioneering and Lean Business Services are joining forces to boost healthcare innovation and AI-driven biomedical research in Saudi Arabia, supporting national goals.